2027 아카데미 여우주연상 예측: 받은 상과 배당률 비교

Her odds climbed from 73.1% to 86.1% in a month, the fastest rise in the top five.

About $523 million on a budget under $1 million, and third on Gold Derby, with the experts 20 points behind the users.

A breakout thriller role that surged from unranked in August to runner-up on mainstream prediction boards after New York Film Festival acclaim.

The critical dare: 84.9% to be nominated, with AwardsDaily warning the movie rests entirely on her.

Gold Derby’s No. 3 in some updates (≈86–88%) and a Critics Choice horror-actress winner, but the prize is genre-specific and the film’s awards profile is narrower than the top two.

Her 95% RT horror triumph defies genre bias, yet her market odds lag behind the establishment favorites.

She shared Cannes' best actress prize with Tao Okamoto, and her odds are 62.1%, so she is the only contender with a major festival prize and a top-five price.

A Cannes best-actress prize shared with Tao Okamoto, and editors at 87.5% — while the experts on the same site are down at 42.3%.

Swept European critics' polls with an 88 Metascore, but forecasters price her chances at just 16/1 without a signed North American major distributor.

Cannes Best Actress, but shared: half a trophy and half the pundit oxygen with co-winner Tao Okamoto.

Gold Derby combined odds around 60% in some updates, but no major best-actress prize this season — a pure odds play rather than a prizes play.

Her shared Cannes crown translates into solid market odds, though she remains an outlier in an American-dominated field.

Her odds fell from 80.8% to 86.1% in the snapshots, still second, without a prize to back them.

Second on Gold Derby at 84.79%, with a 3.8% expert win share and no jury acting prize.

Carries an 8/1 odds line thanks to an aggressive theatrical rollout that contrasts with divided festival jury ballots.

Tied with Navarrette at 84.9%, but carrying a director-star campaign and a Best Picture-adjacent film.

Second on Gold Derby’s combined-odds chart (≈88.5–89.9%) and poised to become the first woman to direct herself to an Oscar acting nomination, but she has no major critics’ prize for this role.

She was nominated for the 2026 Oscars after no precursor wins; this season's odds are 46.2% to 50%.

A major Cannes competition title gives Reinsve a festival-backed route into the conversation, but the retrieved forecast snapshots do not establish a reliable exact odds position.

The Palme d’Or is the film’s, not hers, and Gold Derby’s editors have her in only 25% of their fives.

The May line favorite has cooled into a coattail contender: still everywhere on critics' lists, no longer alone at the top.

A 51% Kalshi nomination favorite whose Cannes acclaim easily outpaces her film's US theatrical footprint.

A Golden Globe drama contract at 64%, a Metascore of 68, and no competitive acting prize.

One September forecast had her winning the category; the broader market still treats her as a respected outsider.

Appears in Gold Derby combined-odds updates at roughly 25% — far below the top tier and without a major 2026 critics’ prize.

Her 44% market odds vastly exceed her film's 68 Metascore, driven by the Academy's historic affinity for advocacy biopics.

She took the Volpi Cup for her first lead role, first festival and first film award, and she is in no odds list I found.

Venice’s Best Actress winner also starred in its Golden Lion film, the season’s most concentrated festival-and-performance signal so far.

Volpi Cup and the Golden Lion in one night — her first lead and her first festival — with a Danish opening set for February 4, 2027.

The NYFF/A24 whisper: AwardsDaily says she could win, yet Gold Derby's top three has no room for her.

Listed at roughly 10% in some Gold Derby combined-odds updates — a long-shot whose inclusion here reflects the thinness of the field below the top six.

Her critical praise in a divisive satire creates a gap, lacking the traditional campaign reach of her studio rivals.